The salvianolic acid including salvianolic acid A, salvianolic acid B, and a mixture of salvianolic acids can reduce myocardial infarct size and promote the expression of VEGF and BVD in animal model experiments of MI, suggesting that salvianolic acid has cardioprotective function through promoting angiogenesis in the animal model of MI. Here, VEGFA is linked to myocardial infarction.